Edgar Tracker

BCTXL BriaCell Therapeutics Corp.

Nasdaq, Nasdaq, Nasdaq · CIK 1610820 · Pharmaceutical Preparations

SEC company page

Public articles

No public articles yet. Follow BCTXL to track filings and write notes.

Recent filings

–

Form Filed Title Accession
10-K2026-10-2810-K0001493152-26-049041
8-K2026-06-267.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001493152-26-030286
10-Q2026-06-0910-Q0001493152-26-027928
8-K2026-06-031.01 Entry into a Material Definitive Agreement · 3.02 Unregistered Sales of Equity Securities · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001493152-26-026953
424B52026-06-02424B50001493152-26-026759
8-K2026-03-317.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001493152-26-014156
10-Q2026-03-1010-Q0001493152-26-009557
8-K2026-03-095.07 Submission of Matters to a Vote of Security Holders0001493152-26-009382
25-NSE2026-02-26—0001354457-26-000220
8-K2026-02-208.01 Other Events · 9.01 Financial Statements and Exhibits0001493152-26-007587
DEF 14A2026-02-12DEF 14A0001493152-26-006390
SCHEDULE 13G2026-01-23—0001104659-26-006332
8-K2026-01-151.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001493152-26-002430
424B42026-01-14424B40001493152-26-002258
EFFECT2026-01-13—9999999995-26-000157
S-1MEF2026-01-13S-1MEF0001493152-26-002103
CERT2026-01-13—0001354457-26-000037
8-A12B2026-01-138-A12B0001493152-26-001969
CORRESP2026-01-08—0001493152-26-000962
CORRESP2026-01-08—0001493152-26-000961